A shingles vaccine may help prevent shingles. People who are eligible should get the Shingrix vaccine, which has been available in the United States since its approval by the Food and Drug Administration in 2017. The Zostavax vaccine is no longer available in the U.S., but other countries may still use it.
Shingrix is approved and recommended for people age 50 and older, whether they've had shingles or not. People who've had the Zostavax vaccine in the past or don't know whether they've had chickenpox may also receive the Shingrix vaccine.
Shingrix is also recommended for people who are 19 years of age and older who have weakened immune systems due to disease or medication.
Shingrix is a nonliving vaccine made of a virus component. It's given in two doses, with 2 to 6 months between doses. The most common side effects of the shingles vaccine are redness, pain and swelling at the injection site. Some people also experience fatigue, headache and other side effects.
The shingles vaccine doesn't guarantee that you won't get shingles. But this vaccine will likely reduce the course and severity of the disease. And it will likely lower your risk of postherpetic neuralgia. Studies suggest that Shingrix offers protection against shingles for more than five years.
Talk to your health care provider about your vaccination options if you:
- Have had an allergic reaction to any component of the shingles vaccine
- Have a weakened immune system due to a condition or medication
- Have had a stem cell transplant
- Are pregnant or trying to become pregnant
The shingles vaccine is used only as a way to prevent shingles. It's not intended to treat people who currently have the disease.